Vertex Stock Recently Hit All-Time High, Leads 8 Top Performers New To IBD Stock Lists Investor's Business Daily 9 hours
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy The Motley Fool 3 weeks
Vertex’s Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares Investor's Business Daily 4 weeks
If You’d Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here’s How Much You’d Have Today The Motley Fool 1 month
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks 2 months
What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences Seeking Alpha 2 months
Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal Investing.com 2 months
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note Zacks 2 months
Vertex Pharmaceuticals bets on kidney disease treatment with $4.9 billion Alpine Immune deal CNBC 2 months
This Growth Stock Is One Step Closer to Launching a New Blockbuster: Time to Buy? The Motley Fool 2 months
Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here’s What You Need to Know Zacks 2 months